Sochi Awards RUB 109.6 Million Public Bus Transportation Contract to Municipal Operator Sochiavtotrans
13 Dec 2025
OvervewA significant public transport contract for the regular bus transportation of passengers has been awarded by the Department of Transport and Road Facilities of the Administration of the City District Resort City of Sochi. The contract, which was signed on December 1, 2025, and valued at RUB 109.6 million, reaffirmed the city's dedication to providing dependable and easily accessible public transport services.Details of the ContractThe contract (No. 122/18.04-04) is presently in the execution stage and covers scheduled bus transport services throughout Sochi. The contract was signed under Article 93 of Federal Law No. 44-FZ after the electronic auction process used for the procurement was eventually ruled invalid.Highlights of the contract includeValue of Contract: RUB 109,606,559.74Date of Contract: December 1, 2025Method of Procurement: Electronic auction (finished with a single supplier)Date of Contract Registration: December 1, 2025Banking Assistance: NeededLocation of the Project: Sochi, Russia's Krasnodar RegionOrganisations InvolvedPurchaser: Department of Transportation and Road Facilities, Sochi Municipal Formation City District Resort City AdministrationMunicipal Unitary Enterprise "Sochiavtotrans" was the winning supplier.Address: Sochi, Krasnodar Region; Gorkogo Street, 56A, Building 1Contact: sochiavtotrans@mail.ru | +7 862 227 0131After the unsuccessful competitive process, Sochiavtotrans, the city's municipal transport operator, was chosen to guarantee the continuation of vital public transport services.Importance of the Agreement Importance of the AgreementIn a major resort city with high seasonal passenger volumes, public bus transport is essential to Sochi's urban mobility. This agreement guarantees the continuous operation of regular bus routes, benefiting locals, commuters, and visitors alike.The award also emphasises how municipal transport companies play a crucial role in protecting vital services in situations where market-based procurement processes are unable to draw in or qualify enough bidders.An Overview of the Winning Entity An Overview of the Winning EntityThe main municipal public transportation provider in Sochi, MUP Sochi "Sochiavtotrans", is in charge of running city bus routes and ensuring transportation dependability. The company has a great deal of experience supporting the city's mobility infrastructure and overseeing large-scale passenger transport operations.In conclusionIn conclusionUnder municipal supervision, Sochiavtotrans will continue to offer regular passenger bus services under the terms of the RUB 109.6 million contract. In addition to securing stable urban transport operations, the agreement highlights the city administration's commitment to public accessibility, service continuity, and transport reliability.RussiaTenders: Russia's Most Recent Government Contract Awards and Tenders RussiaTenders is your reliable resource for the most recent Russian contract awards, RFPs, RFQs, and government tenders Visit RussiaTenders to stay informed about the most recent public procurement opportunities and tender notices in RussiaRussiaTenders has all of the Russian government's contract award notices, eProcurement updates, and tendersUse RussiaTenders, the RussiaTenders portal, to investigate current bids, tenders, and procurement opportunities in RussiaRussiaTenders provides you with contract awards, procurement news, and verified tenders from Russia #Russia #Sochi #PublicTransport #BusServices #ContractAward #TenderResults #GovernmentContracts #Mobility #MunicipalTransport #Sochiavtotrans #TransportProcurement
Read More
Novourengoy Central City Hospital Awards RUB 110 Million Contract for Therapeutic Nutrition Services
13 Dec 2025
OverviewA significant public contract for the provision of therapeutic nutrition services for inpatients has been granted by Novourengoy Central City Hospital, the State Budgetary Healthcare Institution of the Yamal-Nenets Autonomous Okrug. On November 28, 2025, the RUB 110 million contract was signed, enhancing clinical support services for hospitalised patients in northern Russia.Details of the ContractThe arrangement and provision of medical and therapeutic nutrition for patients receiving inpatient treatment are covered by the contract (No. 0190200000325013429/15). The agreement, which was awarded through an open electronic competition, is presently in the execution stage and will guarantee diet-specific nutrition services that are compliant and customised to medical prescriptions.Highlights of the contract include:RUB 110,000,000 is the contract value.Date of Contract: November 28, 2025Method of Procurement: Electronic open competitionEntry into the Contract Register: November 28, 2025Treasury/Banking Support: Not necessaryLocation: Yamal-Nenets Autonomous Okrug, Russian FederationThe contract allows for flexibility based on patient volume and clinical requirements because it does not specify fixed quantities due to the nature of healthcare services.Participating EntitiesPurchaser: "Novourengoy Central City Hospital", the Yamal-Nenets Autonomous District's State Budgetary Health InstitutionLLC "Ecopolis" was the winning supplier.Address: Nagatino-Sadovniki District, Moscow, Kashirskoye HighwayContact: info@ecopolis.group | +7 495 640 5221LLC Ecopolis was chosen due to its technical proficiency and adherence to healthcare nutrition regulations.Contractual SignificanceA vital part of inpatient care, therapeutic nutrition has a direct impact on patient well-being, treatment efficacy, and recovery outcomes. Hospitalised patients will receive medically prescribed diets that adhere to clinical, hygienic, and nutritional standards thanks to this contract.The agreement also guarantees operational continuity and dependable food services within the regional healthcare system for the Yamal-Nenets Autonomous Okrug, where climatic conditions present logistical challenges.An Overview of the Winning CompanyLLC. Ecopolis is a Russian company that specialises in medical nutrition and institutional catering. The company has experience providing diet-specific meal services that are in line with clinical and regulatory requirements while working with healthcare and public-sector organisations.In conclusionNovourengoy Central City Hospital now has a dependable partner for therapeutic nutrition services for the duration of the current execution period thanks to this RUB 110 million contract. The award emphasises how crucial non-clinical healthcare services are becoming to enhancing patient outcomes and upholding hospital operational standards throughout Russia's public healthcare system.RussianTenders: Current Government Contract Awards and Tenders in RussiaRussianTenders is your reliable resource for the most recent contract awards, RFPs, RFQs, and government tenders in RussiaRussianTenders provides you with contract awards, procurement news, and verified tenders from Russia and around the globe Visit RussianTenders to stay informed about the most recent Russian public procurement opportunities and tender notices Visit RussianTenders to access all Russian government tenders, eProcurement updates, and contract award notificationsUse RussianTenders, the Russian Tenders portal, to view live bids, tenders, and procurement opportunities in Russia#Russia #YamalNenets #HealthcareProcurement #ContractAward #TherapeuticNutrition #HospitalCatering #PublicTender #GovernmentContracts #NovourengoyHospital #Ecopolis
Read More
Moscow’s City Clinical Hospital Awards ₽184 Million Bevacizumab Supply Contract to JSC Biocad
12 Dec 2025
JSC Biocad has been given a significant contract by Moscow's State Budgetary Healthcare Institution, "City Clinical Hospital named after S.S. Yudin," to supply the drug bevacizumab through 2026. The hospital's oncology treatment programmes will be supported by the ₽184,053,847.80 single-supplier contract, which was signed on November 26, 2025, and will last until January 20, 2027.Details of the ContractClause 48 of Part 1 of Article 93 of Law No. 44-FZ, which permits procurement from a single supplier due to specialised production requirements and regulated pricing, was used to execute the contract (No. 1/26-Biocad). Important contract information consists of: ₽184,053,847.80 is the contract price. The Russian Ruble (₽) is the currency. Start of Execution: November 26, 2025 Date of Completion: January 20, 2027 Delivery Address: Akademika Millionshchikova Street, 1, Nagatino-Sadovniki Municipal District, Moscow, Russia Banking Assistance: Not necessary Penalties: The contract stipulates that fines for unmet obligations will be deducted. Organisations Involved Client: Moscow's "City Clinical Hospital named after S.S. Yudin", a state-funded medical facility Provider: JSC Biocad (INN: 5024048000, St. Petersburg) Address: Svyaz Street, house 38, block 1, premises 89, Strelna settlement Contact: +7 (495) 992-66-28 | bykova_y@biocad.ru Bevacizumab, a targeted therapy commonly used in oncology, is supplied by JSC Biocad, a prominent Russian biopharmaceutical company, guaranteeing continuity of care for patients at one of Moscow's top clinical hospitals.Importance of the AgreementA monoclonal antibody called bevacizumab is essential for the treatment of several cancers, such as renal cell carcinoma, lung cancer, and colorectal cancer. By obtaining this contract, the hospital strengthens Moscow's public healthcare system's ability to provide cutting-edge oncology care by guaranteeing continuous access to life-saving treatments.The specialised nature of the medication and the need to uphold controlled pricing and production standards in compliance with Russian law are reflected in the single-supplier procurement.Background on JSC BiocadA well-known biopharmaceutical business in Russia, JSC Biocad specialises in the creation, manufacturing, and distribution of cutting-edge medications, such as monoclonal antibodies and cancer treatments. The company has a long history of providing vital pharmaceutical products to public health organisations and government hospitals.In conclusionThe agreement between JSC Biocad and Moscow's City Clinical Hospital ensures that bevacizumab will be available through January 2027 to support ongoing cancer treatment initiatives. This agreement guarantees Moscow patients' continuous access to necessary medications as well as regulatory compliance.RussiaTenders: Russia's Most Recent Government Contract Awards and Tenders RussiaTenders is your reliable resource for the most recent Russian contract awards, RFPs, RFQs, and government tenders Visit RussiaTenders to stay informed about the most recent public procurement opportunities and tender notices in RussiaRussiaTenders has all of the Russian government's contract award notices, eProcurement updates, and tendersUse RussiaTenders, the RussiaTenders portal, to investigate current bids, tenders, and procurement opportunities in RussiaRussiaTenders provides you with contract awards, procurement news, and verified tenders from Russia #Moscow #CityClinicalHospital #Bevacizumab #JSCBiocad #ContractAward #TenderResults #PharmaceuticalSupply #OncologyTreatment #GovernmentProcurement #RussianHealthcare
Read More